Omada Health Files S-1/A for IPO, Eyes Public Market Debut
Ticker: OMDA · Form: S-1/A · Filed: May 29, 2025 · CIK: 1611115
| Field | Detail |
|---|---|
| Company | Omada Health, Inc. (OMDA) |
| Form Type | S-1/A |
| Filed Date | May 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: Digital Health, IPO, S-1/A Filing, Emerging Growth Company, Healthcare Technology, Chronic Disease Management, SEC Filing
TL;DR
**Omada Health's S-1/A filing means their IPO is imminent, making it a speculative buy for growth-focused investors in the digital health space.**
AI Summary
Omada Health, Inc. filed an S-1/A on May 29, 2025, for its initial public offering, indicating its intent to commence the proposed sale of securities as soon as practicable. The company, classified under Health Services (SIC 8000), is headquartered at 500 Sansome Street, San Francisco, CA. As an emerging growth company and a non-accelerated filer, Omada Health will benefit from reduced disclosure requirements. The filing lists Sean Duffy as CEO and agent for service, with legal counsel provided by Latham & Watkins LLP and Davis Polk & Wardwell LLP. While specific revenue and net income figures are not detailed in this excerpt, the amendment signifies a critical step towards public trading, aiming to raise capital for future growth and expansion in the digital health market. The company's strategic outlook likely involves scaling its virtual care programs for chronic disease management, a competitive and rapidly expanding sector.
Why It Matters
This S-1/A filing signals Omada Health's imminent public offering, providing investors with an opportunity to gain exposure to the rapidly growing digital health sector. For employees, it could mean liquidity for equity holdings and increased scrutiny on performance. Customers may see enhanced service offerings as the company gains capital for innovation, while the broader market will observe how Omada Health competes with established players like Teladoc Health and Livongo (now part of Teladoc) in chronic disease management. The IPO will also set a valuation benchmark for other private digital health companies.
Risk Assessment
Risk Level: medium — Omada Health is classified as an 'emerging growth company' and a 'non-accelerated filer,' which means it will be subject to reduced disclosure requirements, potentially limiting investor access to critical financial and operational details compared to larger, more mature public companies. The digital health market is also highly competitive, with significant regulatory and technological risks that could impact Omada's future performance.
Analyst Insight
Investors should closely monitor the final prospectus for detailed financial performance, valuation, and specific use of proceeds. Given the 'emerging growth company' status, a deeper dive into competitive landscape and management's experience will be crucial before making an investment decision.
Executive Compensation
| Name | Title | Total Compensation |
|---|---|---|
| Sean Duffy | Chief Executive Officer |
Key Numbers
- 0001611115 — Central Index Key (CIK) (Unique identifier for Omada Health, Inc. with the SEC.)
- 8000 — Standard Industrial Classification (SIC) Code (Indicates Omada Health operates in 'SERVICES-HEALTH SERVICES'.)
- 333-287156 — SEC File Number (Registration number for Omada Health's S-1 filing.)
- 2025-05-29 — Filing Date (Date the S-1/A amendment was filed with the SEC.)
- 888-987-8337 — Business Phone Number (Contact number for Omada Health, Inc.)
Key Players & Entities
- Omada Health, Inc. (company) — Registrant for S-1/A filing
- Sean Duffy (person) — Chief Executive Officer of Omada Health, Inc.
- Kathleen M. Wells (person) — Counsel at Latham & Watkins LLP
- Richard Kim (person) — Counsel at Latham & Watkins LLP
- Josh B. Landis (person) — Counsel at Latham & Watkins LLP
- Nathan Salha (person) — Omada Health, Inc. contact
- Alan F. Denenberg (person) — Counsel at Davis Polk & Wardwell LLP
- Emily Roberts (person) — Counsel at Davis Polk & Wardwell LLP
- U.S. Securities and Exchange Commission (regulator) — Regulatory body for S-1/A filing
- Latham & Watkins LLP (company) — Legal counsel for Omada Health, Inc.
FAQ
What is Omada Health, Inc.'s primary business according to the S-1/A filing?
According to the S-1/A filing, Omada Health, Inc.'s primary business falls under the Standard Industrial Classification (SIC) Code 8000, which corresponds to 'SERVICES-HEALTH SERVICES'. This indicates their focus on providing health-related services, likely in the digital health sector.
When did Omada Health, Inc. file its S-1/A amendment?
Omada Health, Inc. filed its S-1/A amendment with the U.S. Securities and Exchange Commission on May 29, 2025, as indicated by the 'FILED AS OF DATE: 20250529' in the filing header.
Who is the Chief Executive Officer of Omada Health, Inc.?
Sean Duffy is listed as the Chief Executive Officer of Omada Health, Inc. and also serves as the agent for service, with contact information at 500 Sansome Street, San Francisco, California 94111.
What is Omada Health's status regarding SEC filer classifications?
Omada Health, Inc. is classified as a 'non-accelerated filer' and an 'emerging growth company' according to the check marks in the S-1/A filing. This status allows them certain exemptions from reporting requirements.
What is the address of Omada Health, Inc.'s principal executive offices?
The principal executive offices of Omada Health, Inc. are located at 500 Sansome Street, Suite 200, San Francisco, California 94111, with a business phone number of (888) 987-8337.
Which law firms are providing legal counsel for Omada Health's S-1/A filing?
Latham & Watkins LLP, with contacts Kathleen M. Wells, Richard Kim, and Josh B. Landis, and Davis Polk & Wardwell LLP, with contacts Alan F. Denenberg and Emily Roberts, are providing legal counsel for Omada Health, Inc.'s S-1/A filing.
What is the significance of Omada Health being an 'emerging growth company'?
As an 'emerging growth company,' Omada Health, Inc. is subject to reduced disclosure requirements under the Securities Act of 1933, which can include fewer financial statement disclosures and exemptions from certain executive compensation rules, potentially easing their path to an IPO.
What is the registration number for Omada Health's S-1 filing?
The registration number for Omada Health, Inc.'s S-1 filing, as specified in the S-1/A, is 333-287156.
When is the proposed sale to the public expected to commence for Omada Health?
The approximate date of commencement of the proposed sale to the public for Omada Health, Inc. is stated as 'As soon as practicable after the effective date of this Registration Statement.'
What is Omada Health, Inc.'s state of incorporation?
Omada Health, Inc. is incorporated in Delaware, as stated in the S-1/A filing under 'State or other jurisdiction of incorporation or organization'.
Industry Context
Omada Health operates within the rapidly expanding digital health market, specifically focusing on virtual care programs for chronic disease management. This sector is highly competitive, with numerous players vying for market share through innovative digital solutions and value-based care models. The increasing adoption of telehealth and remote patient monitoring by both consumers and healthcare providers presents significant growth opportunities.
Regulatory Implications
As a healthcare services provider, Omada Health is subject to stringent regulations, including HIPAA for patient data privacy and security. Compliance with evolving healthcare policies and reimbursement models is critical for its business operations and financial performance. The company must navigate these regulatory landscapes to ensure continued access to its target markets and maintain patient trust.
What Investors Should Do
- Monitor subsequent SEC filings for detailed financial statements and business operations.
- Assess the competitive landscape and Omada Health's differentiation strategy.
- Evaluate the company's ability to scale its virtual care programs effectively.
Key Dates
- 2025-05-29: Filing of S-1/A Amendment — Indicates Omada Health's intent to proceed with its initial public offering, signaling a significant step towards becoming a publicly traded company.
Glossary
- S-1/A
- An amendment to a registration statement filed with the SEC, used to update or correct information before a securities offering becomes effective. (This filing is a crucial step for Omada Health to provide updated information to potential investors before its IPO.)
- Emerging Growth Company
- A company with total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year, eligible for reduced reporting requirements under the JOBS Act. (Omada Health qualifies as an emerging growth company, which allows for scaled disclosure requirements, potentially making the IPO process more efficient.)
- Non-accelerated filer
- A filer that does not meet the thresholds for accelerated or large accelerated filer status, typically indicating a smaller market capitalization and less frequent reporting requirements. (Omada Health's classification as a non-accelerated filer, along with being an emerging growth company, suggests it will have fewer ongoing disclosure obligations post-IPO.)
- SIC Code
- Standard Industrial Classification code, a four-digit number used to classify businesses by the type of activity they are engaged in. (Omada Health's SIC code of 8000 ('SERVICES-HEALTH SERVICES') categorizes it within the healthcare services industry, providing context for its business operations.)
Year-Over-Year Comparison
This is the initial S-1/A filing for Omada Health's IPO, so a direct comparison of key metrics to a previous year's filing is not applicable at this stage. The filing serves as the foundational document for potential investors, outlining the company's business, strategy, and risks as it prepares to go public. Future amendments and the final prospectus will provide more detailed financial information and potentially year-over-year comparisons.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on May 29, 2025 by Sean Duffy regarding Omada Health, Inc. (OMDA).